Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis

被引:14
作者
Shi, Dong-Tao [1 ]
Han, Mei [2 ]
Gao, Nan [1 ]
Tian, Wenyan [1 ]
Chen, Weichang [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou 215006, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Special Requirement Ward, Suzhou 215006, Peoples R China
基金
中国国家自然科学基金;
关键词
RASSF1A; Methylation; Gastric cancer; Risk; Tumor suppressor gene; CPG ISLAND METHYLATION; TUMOR-RELATED GENES; EPIGENETIC INACTIVATION; DNA METHYLATION; HYPERMETHYLATION; SUPPRESSOR; PROFILE; SERUM;
D O I
10.1007/s13277-013-1123-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ras-association domain family 1A (RASSF1A), a candidate tumor suppressor gene, is frequently silenced and inactivated by hypermethylation of its promoter region in several human tumors. However, the association between RASSF1A promoter methylation and gastric cancer risk remains conflicting. The aim of this study was to assess the association of RASSF1A promoter methylation with gastric cancer risk by a comprehensive meta-analysis. Relevant studies were identified by searches of PubMed and Web of Science databases with no restrictions. Combined odds ratio (OR) and 95 % confidence interval (CI) were used to assess the strength of the association between RASSF1A promoter methylation and gastric cancer risk. A chi-square-based Q test and sensitivity analyses were performed to test the between-study heterogeneity and the contributions of single studies to the final results, respectively. Funnel plots were carried out to evaluate publication bias. Overall, a significant association was observed between RASSF1A promoter methylation and gastric cancer risk (OR, 12.67; 95 % CI, 8.12-19.78; p < 0.001) with no between-study heterogeneity. Subgroup analyses further revealed that gastric cancer risk was increased for individuals carrying the methylated RASSF1A compared with those with unmethylated RASSF1A. In addition, no publication bias was detected in the overall and subgroup analyses. This study identified a strong association between RASSF1A promoter methylation and risk of gastric cancer and highlighted a promising potential for RASSF1A promoter methylation in gastric cancer risk prediction.
引用
收藏
页码:943 / 948
页数:6
相关论文
共 50 条
  • [21] The Association of RAS Association Domain Family Protein1A (RASSF1A) Methylation States and Bladder Cancer Risk: A Systematic Review and Meta-Analysis
    Gao, Tianyi
    Wang, Shukui
    He, Bangshun
    Pan, Yuqin
    Song, Guoqi
    Gu, Ling
    Chen, Liping
    Nie, Zhenling
    Xu, Yeqiong
    Li, Rui
    PLOS ONE, 2012, 7 (11):
  • [22] Prognostic significance of RASSF1A promoter methylation in operable breast cancer
    Kioulafa, Magdalini
    Kaklamanis, Loukas
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Lianidou, Evi S.
    CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) : 970 - 975
  • [23] Association between Cigarette Smoking and RASSF1A Gene Promoter Hypermethylation in Lung Cancer Patients: a Meta-analysis
    Wu, Xiao-Ming
    Chen, Yu
    Shao, Yang
    Zhou, Xiao-Long
    Tang, Wen-Ru
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (19) : 8451 - 8454
  • [24] Promoter methylation and expression of RASSF1A genes as predictors of disease progression in colorectal cancer
    Zheng, Wei-Wei
    Zhao, Lun-De
    Wang, Gao-Xiang
    Kang, Xiao-Chun
    Qin, Lei
    Ji, Juan-Juan
    Hao, Sha
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 2027 - 2036
  • [25] The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics
    Shao, Chihao
    Dai, Wenzhu
    Li, Haili
    Tang, Wenru
    Jia, Shuting
    Wu, Xiaoming
    Luo, Ying
    PLOS ONE, 2017, 12 (02):
  • [26] Relationships between MGMT promoter methylation and gastric cancer: a meta-analysis
    Yu, Dan
    Cao, Tao
    Han, Ya-Di
    Huang, Fu-Sheng
    ONCOTARGETS AND THERAPY, 2016, 9 : 6049 - 6057
  • [27] Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis
    Shi, Hua
    Wang, Xiaojing
    Wang, Jianbo
    Pan, Jundi
    Liu, Junwei
    Ye, Bin
    ONCOTARGETS AND THERAPY, 2016, 9 : 7409 - 7414
  • [28] Prognostic Effects of RASSF1A, BRCA1, APC, and p16 Promoter Methylation in Ovarian Cancer: A Meta-Analysis
    Chen, Cheng
    Zhu, Ying
    Zhang, Haibo
    Xiao, Lan
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2024, 89 (05) : 363 - 375
  • [29] Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis
    Fan, Xiao-yuan
    Hu, Xin-lei
    Han, Tie-mei
    Wang, Na-na
    Zhu, Yi-miao
    Hu, Wen
    Ma, Zhen-hua
    Zhang, Chen-jing
    Xu, Xiang
    Ye, Zai-yuan
    Han, Chun-mao
    Pan, Wen-sheng
    BMC GASTROENTEROLOGY, 2011, 11
  • [30] Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients
    Balgkouranidou, I.
    Matthaios, D.
    Karayiannakis, A.
    Bolanaki, H.
    Michailidis, P.
    Xenidis, N.
    Amarantidis, K.
    Chelis, L.
    Trypsianis, G.
    Chatzaki, E.
    Lianidou, E. S.
    Kakolyris, S.
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2015, 778 : 46 - 51